TrialEpilepsia2021

Final results from a Phase 3, long-term, open-label, repeat-dose safety study of diazepam nasal spray for seizure clusters in patients with epilepsy.

James W Wheless et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.